On-Demand Webinar

Expanding the Cre-lox Toolbox: Advanced Targeting and a Comprehensive Repository of Conditional Mouse Models

About the webinar:

Cre-lox technology remains a cornerstone of studying gene function and modeling disease. This joint Cyagen-Taconic webinar highlights Cyagen’s newly launched repository of >200 Cre and reporter mice and >16,000 knockout (KO) and conditional knockout (cKO) mouse models developed using advanced gene-targeting, refined recombinases and validation approaches, and now distributed throughout North America and Europe through Taconic Biosciences.

Attendees will gain an understanding of Cyagen’s innovative design pipeline, strategies for verifying Cre expression and specificity, and Taconic’s best practices for breeding and maintaining Cre x floxed lines to ensure experimental reproducibility and translational relevance across research and development applications. Presentations will be followed by an interactive panel discussion and Q&A session.

Accelerate Discovery with Taconic and Cyagen

Taconic and Cyagen Biosciences offer a library of 16,000+ cKO/KO and 200+ Cre Tool and Reporter mouse models, eliminating the need for de novo generation. Combined with Taconic’s integrated embryology and colony management services, this enables faster, more cost-effective research progress.

Visit the repository and learn how we can advance your preclinical research.

Watch the Webinar

Meet the Team

Speaker:

Philip Dubé, PhD

Director, Scientific Marketing | Taconic Biosciences

Dr. Philip Dubé is a scientist at Taconic Biosciences with over 18 years of experience in rodent model use. As Director of Scientific Marketing at Taconic, he is responsible for overseeing scientific content generation, scientific communications and educational initiatives. His areas of expertise include mouse models for immunology, oncology, immuno-oncology, and inflammatory bowel disease (IBD). Dr. Dubé earned his Ph.D. in physiology and an Honors B.Sc. in pharmacology from the University of Toronto. He completed postdoctoral fellowships in IBD research at Vanderbilt University and Children’s Hospital Los Angeles and has served as an Institutional Animal Care and Use Committee member.

Speaker:

Marvin Ouyang, PhD

Vice President, Chief Scientific Officer | Cyagen

As the Chief Scientific Officer at Cyagen, Dr. Ouyang oversees the company’s scientific operations and strategic development of genetically engineered mouse model services. With over two decades of experience in the field, Dr. Ouyang has led innovations that have advanced Cyagen’s global leadership in custom model generation. He is passionate about bridging cutting-edge technologies with translational research to accelerate biomedical discoveries. Before joining Cyagen in 2012, Dr. Ouyang served as the head of Molecular Biology at Taconic Biosciences.

Moderator:

Qiming Wang, PhD

Director of Product Strategy and Strategic Partnerships | Cyagen

Dr. Qiming Wang is a geneticist and strategic leader with a deep background in immunology and preclinical model development. He earned his Ph.D. in Mammalian Genetics through a joint program between Tufts University and The Jackson Laboratory (JAX), where his research on the critical role of B-lymphocytes in autoimmune diseases was published in high-impact journals such as Science Translational Medicine, Diabetes, and the Journal of Immunology.

Today, Dr. Wang channels this extensive scientific insight into his role as Director of Product Strategy and Strategic Partnerships at Cyagen. He is now at the helm of the global expansion for Cyagen's innovative Humanized Genomic Ortholog (HUGO) models, leveraging his unique background to build strategic alliances. Previously, as the Head of Commercial Operations for JAX in China, he spearheaded the organization's market penetration and growth strategy.